Receptor for advanced glycation end-products-mediated inflammation and diabetic vascular complications

Journal of Diabetes Investigation

Volumn 2, Issue 3, 2011, Pages 155-157

  Yamamoto, Yasuhiko ^a   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN S 100; THIAZOLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG MECHANISM; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INFLAMMATION; KIDNEY FAILURE; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VASCULAR DISEASE;

EID: 79961065465     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2011.00125.x     Document Type: Editorial

References (5)

1. Yamamoto Y, Kato I, Doi T, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001; 108: 261-268.
2. Myint KM, Yamamoto Y, Doi T, et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 2006; 55: 2510-2522.
3. Matsumoto S, Yoshida T, Murata H, et al. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction. Biochemistry 2008; 47: 12299-12311.
4. Li J, Qu X, Yao J, et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 2010; 59: 2612-2624.
5. Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370: 1097-1109.